A retrospective study to evaluate the efficacy and safety of Cabazitaxel in patients with castrartion resistant prostate cancer:data from spanish registry.
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2017
At a glance
- Drugs Cabazitaxel (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Mar 2017 New trial record
- 18 Feb 2017 Long term follow up results of final expanded cohort (n=187) presented at the 2017 Genitourinary Cancers Symposium.